✦ LIBER ✦

Basic study and phase I clinic trial of anti-idiotypic antibody mimicking nasopharyngeal carcinoma cell antigen

✍ Scribed by Lu Xie; Guancheng Li; Xiaoling Li; Jianfei Yang; Jiangao Zhu; Guohua Zhou; Xiaohong Cai; Qubing Sun

Book ID: 105671916
Publisher: Chinese Anti-Cancer Association
Year: 1997
Tongue: English
Weight: 416 KB
Volume: 9
Category: Article
ISSN: 1000-9604
DOI: 10.1007/bf02974679

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of 131I-MN-14 F(ab)2 an

Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB

A phase I clinical study of intratumoral

A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck

✍ G. C. MacDonald; M. Rasamoelisolo; J. Entwistle; W. Cuthbert; M. Kowalski; Maure 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 218 KB